SGI
AMPH icon

Summit Global Investments’s Amphastar Pharmaceuticals AMPH Stock Holding History

Summit Global Investments’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-36,238
Closed -$1.67M – 506
2023
Q3 		$1.67M Buy
36,238
+16,394
+83% +$894K 0.11% 143
2023
Q2 		$1.14M Sell
19,844
-17,456
-47% -$774K 0.08% 199
2023
Q1 		$1.4M Buy
37,300
+7,800
+26% +$256K 0.11% 177
2022
Q4 		$827K Buy
29,500
+9,400
+47% +$273K 0.07% 229
2022
Q3 		$565K Sell
20,100
-33,114
-62% -$1.08M 0.05% 286
2022
Q2 		$1.85M Buy
53,214
+8,514
+19% +$304K 0.16% 140
2022
Q1 		$1.6M Sell
44,700
-1,200
-3% -$34K 0.12% 173
2021
Q4 		$1.07M Sell
45,900
-14,600
-24% -$299K 0.07% 225
2021
Q3 		$1.15M Buy
60,500
+13,100
+28% +$257K 0.09% 185
2021
Q2 		$956K Sell
47,400
-146
-0.3% -$2.75K 0.06% 239
2021
Q1 		$871K Sell
47,546
-14,833
-24% -$276K 0.06% 220
2020
Q4 		$1.25M Sell
62,379
-613
-1% -$11.9K 0.13% 131
2020
Q3 		$1.18M Buy
62,992
+552
+0.9% +$11.1K 0.12% 118
2020
Q2 		$1.4M Buy
62,440
+3,800
+6% +$69.6K 0.16% 91
2020
Q1 		$870K Buy
58,640
+9,600
+20% +$167K 0.13% 99
2019
Q4 		$946K Buy
49,040
+6,315
+15% +$121K 0.1% 138
2019
Q3 		$847K Buy
+42,725
New +$890K 0.1% 167

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Summit Global Investments's AMPH Position: Q4 2023 in Review

Summit Global Investments sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2023, closing a stake of 36,238 shares — an estimated $1.67M sold.

Summit Global Investments first reported a position in AMPH in Q3 2019 and held it in 17 quarters. The position peaked at $1.85M in Q2 2022. 276 funds tracked by Wall St. Rank hold AMPH as of Q4 2023.

  • Summit Global Investments reported no remaining Amphastar Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Summit Global Investments sold 36,238 Amphastar Pharmaceuticals shares in Q4 2023, an estimated $1.67M.
  • Summit Global Investments first reported a position in Amphastar Pharmaceuticals in Q3 2019 and held it in 17 quarters.
  • Summit Global Investments's Amphastar Pharmaceuticals position peaked at $1.85M in Q2 2022.
  • 276 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2023.

Based on Summit Global Investments's 13F filing for Q4 2023, filed 6 Feb 2024.